Annika Lenić, Bettina Bardl, Florian Kloss, Gundela Peschel, Ivan Schlembach, Gerald Lackner, Lars Regestein, Miriam A. Rosenbaum
{"title":"Pilot Scale Production of a F420 Precursor Under Microaerobic Conditions","authors":"Annika Lenić, Bettina Bardl, Florian Kloss, Gundela Peschel, Ivan Schlembach, Gerald Lackner, Lars Regestein, Miriam A. Rosenbaum","doi":"10.1002/biot.70002","DOIUrl":null,"url":null,"abstract":"<p>The functional investigation of redox cofactors is important for many potential biocatalytic processes, yet limited access to these molecules is often hampering efficient research activities. Deazaflavin-dependent enzymes mediate a range of biochemical redox reactions in prokaryotes. Coenzyme F<sub>420</sub>-dependent enzymes are interesting for asymmetric redox biocatalysis and other challenging reactions, but low F<sub>420</sub> titers harvested from natural producers and engineered host strains so far limit intensive investigation of these enzymes. F<sub>O</sub> is a natural precursor of F<sub>420</sub>, which already shares many of the redox properties and was previously confirmed as a surrogate for F<sub>420</sub> in certain enzymes. Here, we focused our research on the development of an overall process workflow from a 30-L pilot scale stirred tank bioprocess to an optimized downstream purification process to obtain pure F<sub>O</sub> from an engineered <i>Escherichia coli</i> host strain. We were able to shift the cofactor synthesis from riboflavin to F<sub>O</sub> via the implementation of oxygen-limited process conditions during heterologous <i>fbiC</i> expression and reached a final titer of 5.05 mg L<sup>−1</sup> F<sub>O</sub> in our fermentation broth, which for the first time allows the purification of relevant amounts for subsequent experiments. Online fluorescence measurement within the bioreactor system made it possible to monitor F<sub>O</sub> formation and confirmed growth-associated F<sub>O</sub> biosynthesis.</p>","PeriodicalId":134,"journal":{"name":"Biotechnology Journal","volume":"20 3","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/biot.70002","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology Journal","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/biot.70002","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
The functional investigation of redox cofactors is important for many potential biocatalytic processes, yet limited access to these molecules is often hampering efficient research activities. Deazaflavin-dependent enzymes mediate a range of biochemical redox reactions in prokaryotes. Coenzyme F420-dependent enzymes are interesting for asymmetric redox biocatalysis and other challenging reactions, but low F420 titers harvested from natural producers and engineered host strains so far limit intensive investigation of these enzymes. FO is a natural precursor of F420, which already shares many of the redox properties and was previously confirmed as a surrogate for F420 in certain enzymes. Here, we focused our research on the development of an overall process workflow from a 30-L pilot scale stirred tank bioprocess to an optimized downstream purification process to obtain pure FO from an engineered Escherichia coli host strain. We were able to shift the cofactor synthesis from riboflavin to FO via the implementation of oxygen-limited process conditions during heterologous fbiC expression and reached a final titer of 5.05 mg L−1 FO in our fermentation broth, which for the first time allows the purification of relevant amounts for subsequent experiments. Online fluorescence measurement within the bioreactor system made it possible to monitor FO formation and confirmed growth-associated FO biosynthesis.
Biotechnology JournalBiochemistry, Genetics and Molecular Biology-Molecular Medicine
CiteScore
8.90
自引率
2.10%
发文量
123
审稿时长
1.5 months
期刊介绍:
Biotechnology Journal (2019 Journal Citation Reports: 3.543) is fully comprehensive in its scope and publishes strictly peer-reviewed papers covering novel aspects and methods in all areas of biotechnology. Some issues are devoted to a special topic, providing the latest information on the most crucial areas of research and technological advances.
In addition to these special issues, the journal welcomes unsolicited submissions for primary research articles, such as Research Articles, Rapid Communications and Biotech Methods. BTJ also welcomes proposals of Review Articles - please send in a brief outline of the article and the senior author''s CV to the editorial office.
BTJ promotes a special emphasis on:
Systems Biotechnology
Synthetic Biology and Metabolic Engineering
Nanobiotechnology and Biomaterials
Tissue engineering, Regenerative Medicine and Stem cells
Gene Editing, Gene therapy and Immunotherapy
Omics technologies
Industrial Biotechnology, Biopharmaceuticals and Biocatalysis
Bioprocess engineering and Downstream processing
Plant Biotechnology
Biosafety, Biotech Ethics, Science Communication
Methods and Advances.